Grad Intern – R&D Biostatistics

Amgen

Oct 18, 2023

Applications are closed

Internship
Full-time
Off-cycle Internship
Research & Development
Science
United States
Remote

Requirements

Basic Qualifications:
Amgen requires that all individuals applying for a grad internship or a co-op assignment at Amgen must meet the following criteria:
18 years or older
Graduated with a Bachelor’s degree from an accredited college or university with a 3.0 minimum GPA or equivalent
Currently enrolled in an MBA program for an MBA internship OR a Master’s program for a Master’s internship OR a PharmD program for a PharmD internship OR Ph.D. for a PhD internship from an accredited college or university and completion of the first year of MBA OR Master’s OR Pharm D OR Ph.D. program before the internship starts
Enrolled in an accredited college or university following the potential internship or co-op assignment
Must not be employed at the time the internship starts
Student must be located in the United States for the duration of the internship
Preferred Qualifications:
Pursuing a PhD in Biostatistics, Statistics, or Mathematics
In the process of completing the third year of current program
Proficiency in SAS or R on either a UNIX or NT platform
Ability to lead and deliver results in an interactive matrixed environment
Strong written and oral communication skills, relationship building, and leadership skill

Responsibilities

This position will work closely with a senior-level statistician on topics related to the design and analysis of clinical trials and/or nonclinical research.
Amgen research and development uses science and innovation to dramatically improve people’s lives in various therapeutic areas, including oncology, nephrology, bone metabolism, cardiovascular, and inflammation.
At the conclusion of the internship, this position will give a presentation summarizing the work completed during the program.

Amgen

#WeareBiotech

Science & Healthcare

Industry

10,001+

Employees

1980

Founded Year

Mission & Purpose

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.